Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

832
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
832
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

13.3K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing the spleen-brain axis: Magnolol-loaded nanomedicine attenuates ischemic stroke <i>via</i> oxidative stress mitigation and monocyte/macrophage reprogramming.

Acta pharmaceutica Sinica. B·2026
Same author

The structural basis of RanGAP1 regulation and catalysis in nuclear transport.

bioRxiv : the preprint server for biology·2026
Same author

Antioxidant Nanozymes: From Rational Design to Biomedical Applications.

Research (Washington, D.C.)·2026
Same author

The feasibility of ovarian tissue cryopreservation in selected females after hematopoietic stem cell transplantation.

Bone marrow transplantation·2026
Same author

Nanoporous-based biomaterials in biomedical applications: from fundamentals and biosensing to drug delivery, wound healing, and tissue engineering.

Nanoscale advances·2026
Same author

Long-term assessment of nutrient-induced eutrophication in Xiamen Bay: Implications for integrated watershed-coast management.

Marine environmental research·2026

Related Experiment Video

Updated: Aug 9, 2025

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.9K

Strategy toward Kinase-Selective Drug Discovery.

Mingzhen Zhang1, Yonglan Liu2, Hyunbum Jang1

  • 1Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.

Journal of Chemical Theory and Computation
|February 23, 2023
PubMed
Summary

This study introduces a novel computational method to identify unique structural features within kinase drug pockets, enhancing drug selectivity for cancer research. The approach reveals distinct geometric patterns that can differentiate kinases, paving the way for safer and more effective cancer therapies.

More Related Videos

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.2K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.9K

Related Experiment Videos

Last Updated: Aug 9, 2025

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.9K
Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.2K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.9K

Area of Science:

  • Computational Biology
  • Structural Bioinformatics
  • Drug Discovery

Background:

  • Kinase drug selectivity is a major challenge in cancer research due to structurally similar kinase drug pockets.
  • Off-target inhibitor toxicity frequently causes clinical trial failures.

Purpose of the Study:

  • To develop a transformation-invariant protocol for identifying distinct geometric features in kinase drug pockets.
  • To establish the structural principles of kinase drug selectivity through kinome-wide analysis.
  • To create a generalizable bioinformatic protocol for distinguishing protein structural features.

Main Methods:

  • Integration of experimental structures with AI-based structural kinome data.
  • Kinome-wide structural bioinformatic analysis to generate a structural landscape.
  • Proposal of a binary network model to encapsulate kinase structural information.
  • Unsupervised clustering for feature extraction.

Main Results:

  • All kinases possess binary units shared by fewer than seven other kinases.
  • 331 kinases exhibit unique binary units, potentially distinguishing them from all others.
  • Identified unique structural features (binary units) represent inhibitor-accessible geometric space for kinome-wide selectivity.
  • Applied the method to epidermal growth factor receptor and AKT1 kinase selectivity.

Conclusions:

  • The proposed binary network and clustering method offer a generalizable protocol for extracting distinguishing structural features across protein families.
  • The KDS software facilitates customized visualization and analysis of kinase drug selectivity networks.
  • This approach can significantly advance the design of selective kinase inhibitors, reducing off-target toxicity.